Author Parnetti, Lucilla

1 to 20 of 25 Items
  • 2021 Journal Article
    ​ ​Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study​
    Ribaldi, F.; Altomare, D.; Jovicich, J.; Ferrari, C.; Picco, A.; Pizzini, F. B. & Soricelli, A. et al.​ (2021) 
    Magnetic Resonance Imaging76 pp. 108​-115​.​ DOI: https://doi.org/10.1016/j.mri.2020.11.008 
    Details  DOI 
  • 2020 Journal Article
    ​ ​CSF cutoffs for MCI due to AD depend on APOEε4 carrier status​
    Marizzoni, M.; Ferrari, C.; Babiloni, C.; Albani, D.; Barkhof, F.; Cavaliere, L. & Didic, M. et al.​ (2020) 
    Neurobiology of Aging89 pp. 55​-62​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2019.12.019 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study​
    Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al.​ (2020) 
    PLoS Medicine17(8) pp. e1003289​.​ DOI: https://doi.org/10.1371/journal.pmed.1003289 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity​
    Jovicich, J.; Babiloni, C.; Ferrari, C.; Marizzoni, M.; Moretti, D. V.; Del Percio, C. & Lizio, R. et al.​ (2019) 
    Journal of Alzheimer's Disease69(1) pp. 15​-35​.​ DOI: https://doi.org/10.3233/JAD-180158 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study​
    Albani, D.; Marizzoni, M.; Ferrari, C.; Fusco, F.; Boeri, L.; Raimondi, I. & Jovicich, J. et al.​ (2019) 
    Journal of Alzheimer's Disease69(1) pp. 37​-48​.​ DOI: https://doi.org/10.3233/JAD-180321 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease​
    Marizzoni, M.; Ferrari, C.; Macis, A.; Jovicich, J.; Albani, D.; Babiloni, C. & Cavaliere, L. et al.​ (2019) 
    Journal of Alzheimer's Disease69(1) pp. 49​-58​.​ DOI: https://doi.org/10.3233/JAD-181016 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?​
    Lleó, A.; Parnetti, L.; Belbin, O. & Wiltfang, J. ​ (2019) 
    Clinica Chimica Acta491 pp. 81​-84​.​ DOI: https://doi.org/10.1016/j.cca.2019.01.019 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers​
    Marizzoni, M.; Ferrari, C.; Jovicich, J.; Albani, D.; Babiloni, C.; Cavaliere, L. & Didic, M. et al.​ (2019) 
    Journal of Alzheimer's Disease69(1) pp. 3​-14​.​ DOI: https://doi.org/10.3233/JAD-180152 
    Details  DOI 
  • 2019 Journal Article
    ​ ​CSF and blood biomarkers for Parkinson's disease​
    Parnetti, L.; Gaetani, L.; Eusebi, P.; Paciotti, S.; Hansson, O.; El-Agnaf, O. & Mollenhauer, B. et al.​ (2019) 
    The Lancet Neurology18(6) pp. 573​-586​.​ DOI: https://doi.org/10.1016/S1474-4422(19)30024-9 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​
    Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al.​ (2018) 
    The World Journal of Biological Psychiatry19(4) pp. 244​-328​.​ DOI: https://doi.org/10.1080/15622975.2017.1375556 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
    Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
    Alzheimer's Research & Therapy10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)​
    Nathan, P. J.; Lim, Y. Y.; Abbott, R.; Galluzzi, S.; Marizzoni, M.; Babiloni, C. & Albani, D. et al.​ (2017) 
    Neurobiology of Aging53 pp. 1​-10​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2017.01.013 
    Details  DOI 
  • 2017 Journal Article | 
    ​ ​Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia​
    Chiasserini, D.; Biscetti, L.; Eusebi, P.; Salvadori, N.; Frattini, G.; Simoni, S. & De Roeck, N. et al.​ (2017) 
    Alzheimer's Research & Therapy9(1).​ DOI: https://doi.org/10.1186/s13195-017-0276-4 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques​
    Marchitelli, R.; Minati, L.; Marizzoni, M.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W. & Wiltfang, J.  et al.​ (2016) 
    Human Brain Mapping37(6) pp. 2114​-2132​.​ DOI: https://doi.org/10.1002/hbm.23157 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
    Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
    Journal of Alzheimer's Disease52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a \‘European ADNI study’​
    Galluzzi, S.; Marizzoni, M.; Babiloni, C.; Albani, D.; Antelmi, L.; Bagnoli, C. & Bartrés-Faz, D. et al.​ (2016) 
    Journal of Internal Medicine279(6) pp. 576​-591​.​ DOI: https://doi.org/10.1111/joim.12482 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects​
    Albi, A.; Pasternak, O.; Minati, L.; Marizzoni, M.; Bartrés-Faz, D.; Bargalló, N. & Bosch, B. et al.​ (2016) 
    Human Brain Mapping38(1) pp. 12​-26​.​ DOI: https://doi.org/10.1002/hbm.23350 
    Details  DOI 
  • 2016 Journal Article
    ​ ​The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature​
    Simonsen, A. H.; Kuiperij, B.; El-Agnaf, O. M. A.; Engelborghs, S.; Herukka, S.-K.; Parnetti, L. & Rektorova, I. et al.​ (2016) 
    Biomarkers in Medicine10(1) pp. 19​-34​.​ DOI: https://doi.org/10.2217/BMM.14.105 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Review
    ​ ​Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders​
    Mollenhauer, B.; Parnetti, L.; Rektorova, I.; Kramberger, M. G.; Pikkarainen, M.; Schulz-Schaeffer, W. J.& Aarsland, D. et al.​ (2016)
    Journal of Neurochemistry, 139​ pp. 290​-317​.​
    Wiley-blackwell. DOI: https://doi.org/10.1111/jnc.13390 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly​
    Marizzoni, M.; Antelmi, L.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W.; Wiltfang, J.   & Fiedler, U. et al.​ (2015) 
    Human Brain Mapping36(9) pp. 3516​-3527​.​ DOI: https://doi.org/10.1002/hbm.22859 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page